Zydus Lifesciences has informed that it enclosed a copy of press release dated September 27, 2024, titled ‘Zydus and CSIR-Central Drug Research Institute Lucknow to develop best-in-class drug for chronic kidney disease induced Osteoporosis’.
The above information is a part of company’s filings submitted to BSE.